BACKGROUND: The Short Physical Performance Battery (SPPB) is a well-established measure of lower body physical functioning in older persons but has not been adequately examined in African Americans or younger persons. Moreover, factors associated with changes in SPPB over time have not been reported. METHODS: A representative sample of 998 African Americans (49-65 years old at baseline) living in St. Louis, Missouri were followed for 36 months to examine the predictive validity of SPPB in this population and identify factors associated with changes in SPPB. SPPB was calibrated to this population, ranged from 0 (worst) to 12 (best), and required imputation for about 50% of scores. Adverse outcomes of baseline SPPB included death, nursing home placement, hospitalization, physician visits, incident basic and instrumental activity of daily living disabilities, and functional limitations. Changes in SPPB over 36 months were modeled. RESULTS: Adjusted for appropriate covariates, weighted appropriately, and using propensity scores to address potential selection bias, baseline SPPB scores were associated with all adverse outcomes except physician visits, and were marginally associated with hospitalization. Declines in SPPB scores were associated with low falls efficacy (b = -1.311), perceived income adequacy (-0.121), older age (-0.073 per year), poor vision (-0.754), diabetes mellitus (-0.565), refusal to report household income (1.48), ever had Medicaid insurance (-0.610), obesity (-0.437), hospitalization in the prior year (-0.521), and kidney disease (-.956). CONCLUSIONS: The effect of baseline SPPB on adverse outcomes in this late middle-age African American population confirms reports involving older, primarily white participants. Alleviating deterioration in lower body physical functioning guided by the associated covariates may avoid or delay multiple age-associated adverse outcomes.
BACKGROUND: The Short Physical Performance Battery (SPPB) is a well-established measure of lower body physical functioning in older persons but has not been adequately examined in African Americans or younger persons. Moreover, factors associated with changes in SPPB over time have not been reported. METHODS: A representative sample of 998 African Americans (49-65 years old at baseline) living in St. Louis, Missouri were followed for 36 months to examine the predictive validity of SPPB in this population and identify factors associated with changes in SPPB. SPPB was calibrated to this population, ranged from 0 (worst) to 12 (best), and required imputation for about 50% of scores. Adverse outcomes of baseline SPPB included death, nursing home placement, hospitalization, physician visits, incident basic and instrumental activity of daily living disabilities, and functional limitations. Changes in SPPB over 36 months were modeled. RESULTS: Adjusted for appropriate covariates, weighted appropriately, and using propensity scores to address potential selection bias, baseline SPPB scores were associated with all adverse outcomes except physician visits, and were marginally associated with hospitalization. Declines in SPPB scores were associated with low falls efficacy (b = -1.311), perceived income adequacy (-0.121), older age (-0.073 per year), poor vision (-0.754), diabetes mellitus (-0.565), refusal to report household income (1.48), ever had Medicaid insurance (-0.610), obesity (-0.437), hospitalization in the prior year (-0.521), and kidney disease (-.956). CONCLUSIONS: The effect of baseline SPPB on adverse outcomes in this late middle-age African American population confirms reports involving older, primarily white participants. Alleviating deterioration in lower body physical functioning guided by the associated covariates may avoid or delay multiple age-associated adverse outcomes.
Authors: B W Penninx; L Ferrucci; S G Leveille; T Rantanen; M Pahor; J M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2000-11 Impact factor: 6.053
Authors: Subashan Perera; Stephanie Studenski; Julie M Chandler; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2005-07 Impact factor: 6.053
Authors: Kimberly A Faulkner; Jane A Cauley; Joseph M Zmuda; Douglas P Landsittel; Michael C Nevitt; Anne B Newman; Stephanie A Studenski; Mark S Redfern Journal: J Am Geriatr Soc Date: 2005-10 Impact factor: 5.562
Authors: Jennifer S Brach; Eleanor M Simonsick; Stephen Kritchevsky; Kristine Yaffe; Anne B Newman Journal: J Am Geriatr Soc Date: 2004-04 Impact factor: 5.562
Authors: Fredric D Wolinsky; Theodore K Malmstrom; J Philip Miller; Elena M Andresen; Mario Schootman; Douglas K Miller Journal: J Gerontol B Psychol Sci Soc Sci Date: 2009-02-04 Impact factor: 4.077
Authors: Douglas K Miller; Theodore K Malmstrom; Elena M Andresen; J Philip Miller; Margaret M Herning; Mario Schootman; Fredric D Wolinsky Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-30 Impact factor: 6.053
Authors: Andrea L Rosso; Charles B Eaton; Robert Wallace; Rachel Gold; J David Curb; Marcia L Stefanick; Judith K Ockene; Yvonne L Michael Journal: J Gerontol A Biol Sci Med Sci Date: 2011-02-11 Impact factor: 6.053
Authors: Douglas K Miller; Theodore K Malmstrom; J Philip Miller; Elena M Andresen; Mario Schootman; Fredric D Wolinsky Journal: J Aging Health Date: 2010-01-05
Authors: Lona Mody; Douglas K Miller; Joanne M McGloin; Marcie Freeman; Edward R Marcantonio; Jay Magaziner; Stephanie Studenski Journal: J Am Geriatr Soc Date: 2008-12 Impact factor: 5.562